Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.15p +1.56% 9.75p 9.50p 10.00p 9.75p 9.55p 9.60p 615,462 12:06:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.4 -4.8 -3.2 - 20.12

Futura Medical Share Discussion Threads

Showing 16226 to 16249 of 16650 messages
Chat Pages: Latest  654  653  652  651  650  649  648  647  646  645  644  643  Older
DateSubjectAuthorDiscuss
30/8/2018
15:23
Futura Medical plcJames Barder, Chief Executive Tel: +44 (0)1483 685 670 james.barder@futuramedical.com
lbo
30/8/2018
15:13
Punchy numbers. Yeah, right, KO share price On course to 23p on the interims date. If jam-tomorrow again then it'll be 15p before you'll know it. What a dog.
greedfear
29/8/2018
07:45
James Barder should be fired. Unlike the actual condom he has failed to perform when tested!
lbo
29/8/2018
06:49
Does anyone think this Co will ever deliver a block busting drug Not holding .. but always on watchlist
jailbird
29/8/2018
06:22
What they don't say is often more important than what they do say.They did not say negotiations have stopped,which implies they are very much still on and could conclude any day now.
j777j
29/8/2018
06:17
"and provide a trading update" long awaited news end of sept but no deal yet? The wait for LTH goes on.
wi1l
22/8/2018
14:40
Hm. Sub 27p soon? Seems to be a seller out there.
greedfear
22/8/2018
07:29
and the wait continues
pjj71
21/8/2018
16:20
I'm still waiting for what was hoped for by the end of June ('target date'.. 'punchy numbers') viz. partners for Med2002. I agree that first dosing of the Med2002 phase III dose-ranging efficacy trial will make no lasting difference to the share price The key anticipated milestones there are: "First patient dosed: by end of September 2018 Last patient dosed: by end of June 2019 Headline efficacy results: by end of December 2019" It'd be good to hear of progress on selling CSD too. rrr
rrr
21/8/2018
13:15
But, they'll probably be late (again).
greedfear
21/8/2018
13:13
Then the real spending starts and cash will be needed soon. Dilution.
greedfear
21/8/2018
12:41
j7 fat lot of difference that will make !
mikethebike4
21/8/2018
11:03
Calm down dear.Any day now as only 6 weeks until first dosing of phase 3 trials.
j777j
21/8/2018
07:55
j7 - oh dear !
mikethebike4
20/8/2018
10:46
to say the least rr !
mikethebike4
20/8/2018
10:44
to say the least rr !
mikethebike4
20/8/2018
09:11
Re the share price after an (encouraging) announcement on Med2002, my suspicion is that after a flurry of excitement it would quickly subside to not much more than now unless there is detail that convinces people it will actually lead to sales and profit. Previous "deals" with FUM have proved false dawns, leading to very little income indeed and certainly no profit, so people will be sceptical.
rrr
20/8/2018
09:02
lowest share price since Jan - says it all doesn't it ! - didn't j7 say it was 'head and shoulders above all the rest' ?
mikethebike4
20/8/2018
08:29
Not even a teeny weeny BOOM
rrr
19/8/2018
09:00
Any day of the week RNS. Lets have predictions after next med gel 2002 RNS as to what the share price will be I say 80p to start the balls rolling no pun intended.
shakin not stirred
17/8/2018
13:46
come on J7 - where's all the news you forecast ! - not even "we are making good progress with our many (lacklustra) distributors"
mikethebike4
13/8/2018
15:08
Or, putting it mathematically, BOOM - MOOB = 0.
rrr
13/8/2018
13:01
The silence is deafening.
joestalin
13/8/2018
11:58
What's the opposite of BOOM? Is it MOOB? In which case, MOOOOOOOOB!
thebutler
Chat Pages: Latest  654  653  652  651  650  649  648  647  646  645  644  643  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190117 01:48:21